Parkman Healthcare Partners LLC Alkermes Plc. Transaction History
Parkman Healthcare Partners LLC
- $746 Million
- Q2 2025
A detailed history of Parkman Healthcare Partners LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 200,000 shares of ALKS stock, worth $6.3 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$6.3 Million% of portfolio
0.77%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ALKS
# of Institutions
393Shares Held
176MCall Options Held
558KPut Options Held
427K-
Black Rock Inc. New York, NY29.1MShares$917 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.5MShares$583 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10MShares$316 Million0.03% of portfolio
-
State Street Corp Boston, MA8.21MShares$259 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.41MShares$202 Million1.86% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.18B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...